S&P 500   3,598.89 (-1.08%)
DOW   29,474.31 (-1.46%)
QQQ   296.86 (-0.72%)
AAPL   117.80 (+1.04%)
MSFT   211.79 (-1.60%)
FB   272.94 (-1.75%)
GOOGL   1,756.33 (-1.72%)
AMZN   3,153.99 (-1.29%)
TSLA   580.52 (-0.89%)
NVDA   524.60 (-1.10%)
BABA   265.42 (-4.00%)
CGC   28.41 (-2.03%)
GE   10.26 (-1.35%)
MU   64.17 (-0.09%)
AMD   88.49 (+1.49%)
T   28.92 (-0.38%)
NIO   51.15 (-5.28%)
F   9.10 (+0.11%)
ACB   10.72 (+2.39%)
NFLX   484.67 (-1.36%)
BA   211.37 (-2.37%)
GILD   59.75 (-0.47%)
DIS   147.52 (+0.27%)
S&P 500   3,598.89 (-1.08%)
DOW   29,474.31 (-1.46%)
QQQ   296.86 (-0.72%)
AAPL   117.80 (+1.04%)
MSFT   211.79 (-1.60%)
FB   272.94 (-1.75%)
GOOGL   1,756.33 (-1.72%)
AMZN   3,153.99 (-1.29%)
TSLA   580.52 (-0.89%)
NVDA   524.60 (-1.10%)
BABA   265.42 (-4.00%)
CGC   28.41 (-2.03%)
GE   10.26 (-1.35%)
MU   64.17 (-0.09%)
AMD   88.49 (+1.49%)
T   28.92 (-0.38%)
NIO   51.15 (-5.28%)
F   9.10 (+0.11%)
ACB   10.72 (+2.39%)
NFLX   484.67 (-1.36%)
BA   211.37 (-2.37%)
GILD   59.75 (-0.47%)
DIS   147.52 (+0.27%)
S&P 500   3,598.89 (-1.08%)
DOW   29,474.31 (-1.46%)
QQQ   296.86 (-0.72%)
AAPL   117.80 (+1.04%)
MSFT   211.79 (-1.60%)
FB   272.94 (-1.75%)
GOOGL   1,756.33 (-1.72%)
AMZN   3,153.99 (-1.29%)
TSLA   580.52 (-0.89%)
NVDA   524.60 (-1.10%)
BABA   265.42 (-4.00%)
CGC   28.41 (-2.03%)
GE   10.26 (-1.35%)
MU   64.17 (-0.09%)
AMD   88.49 (+1.49%)
T   28.92 (-0.38%)
NIO   51.15 (-5.28%)
F   9.10 (+0.11%)
ACB   10.72 (+2.39%)
NFLX   484.67 (-1.36%)
BA   211.37 (-2.37%)
GILD   59.75 (-0.47%)
DIS   147.52 (+0.27%)
S&P 500   3,598.89 (-1.08%)
DOW   29,474.31 (-1.46%)
QQQ   296.86 (-0.72%)
AAPL   117.80 (+1.04%)
MSFT   211.79 (-1.60%)
FB   272.94 (-1.75%)
GOOGL   1,756.33 (-1.72%)
AMZN   3,153.99 (-1.29%)
TSLA   580.52 (-0.89%)
NVDA   524.60 (-1.10%)
BABA   265.42 (-4.00%)
CGC   28.41 (-2.03%)
GE   10.26 (-1.35%)
MU   64.17 (-0.09%)
AMD   88.49 (+1.49%)
T   28.92 (-0.38%)
NIO   51.15 (-5.28%)
F   9.10 (+0.11%)
ACB   10.72 (+2.39%)
NFLX   484.67 (-1.36%)
BA   211.37 (-2.37%)
GILD   59.75 (-0.47%)
DIS   147.52 (+0.27%)
Log in
OTCMKTS:ELOX

Eloxx Pharmaceuticals Stock Forecast, Price & News

$2.96
-0.03 (-1.00 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$2.85
Now: $2.96
$3.00
50-Day Range
$2.42
MA: $2.82
$3.04
52-Week Range
$1.44
Now: $2.96
$8.16
Volume13,082 shs
Average Volume113,964 shs
Market Capitalization$118.85 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial that focuses on the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.
Read More
Eloxx Pharmaceuticals logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.25 out of 5 stars


Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ELOX
CUSIPN/A
CIKN/A
Phone858-909-0749
Employees29

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$118.85 million
Next Earnings DateN/A
OptionableNot Optionable
$2.96
-0.03 (-1.00 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ELOX News and Ratings via Email

Sign-up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Eloxx Pharmaceuticals (OTCMKTS:ELOX) Frequently Asked Questions

How has Eloxx Pharmaceuticals' stock price been impacted by Coronavirus (COVID-19)?

Eloxx Pharmaceuticals' stock was trading at $2.88 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ELOX stock has increased by 2.8% and is now trading at $2.96.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Eloxx Pharmaceuticals?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eloxx Pharmaceuticals in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Eloxx Pharmaceuticals
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Eloxx Pharmaceuticals?

Wall Street analysts have given Eloxx Pharmaceuticals a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Eloxx Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Eloxx Pharmaceuticals' earnings last quarter?

Eloxx Pharmaceuticals, Inc. (OTCMKTS:ELOX) posted its quarterly earnings results on Thursday, November, 5th. The company reported ($0.16) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.19) by $0.03.
View Eloxx Pharmaceuticals' earnings history
.

What price target have analysts set for ELOX?

5 equities research analysts have issued 1-year target prices for Eloxx Pharmaceuticals' stock. Their forecasts range from $3.00 to $10.00. On average, they anticipate Eloxx Pharmaceuticals' share price to reach $5.80 in the next twelve months. This suggests a possible upside of 95.9% from the stock's current price.
View analysts' price targets for Eloxx Pharmaceuticals
.

Who are some of Eloxx Pharmaceuticals' key competitors?

What other stocks do shareholders of Eloxx Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eloxx Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), Sorrento Therapeutics (SRNE), VIVUS (VVUS), OPKO Health (OPK), Arbutus Biopharma (ABUS), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA), SCYNEXIS (SCYX), Cerecor (CERC) and Precigen (PGEN).

Who are Eloxx Pharmaceuticals' key executives?

Eloxx Pharmaceuticals' management team includes the following people:
  • Dr. Gregory Williams M.B.A., Ph.D., MBA, CEO & Director (Age 61, Pay $586.7k)
  • Dr. Silvia Noiman M.B.A., Ph.D., MBA, Founder & Director (Age 64, Pay $40k)
  • Mr. Neil S. Belloff Esq., COO, Gen. Counsel & Corp. Sec. (Age 60)
  • Mr. Stephen MacDonald, VP of Fin. & Accounting, Principal Accounting Officer and Treasurer (Age 49)
  • Ms. Barbara Ryan, Investor Relations Officer
  • Ms. Rose Villandry, VP of HR
  • Dr. Thomas Haverty M.D., Chief Medical Officer
  • Mr. Matthew Goddeeris Ph.D., VP of Research

What is Eloxx Pharmaceuticals' stock symbol?

Eloxx Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ELOX."

Who are Eloxx Pharmaceuticals' major shareholders?

Eloxx Pharmaceuticals' stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (3.72%) and State Street Corp (1.11%).
View institutional ownership trends for Eloxx Pharmaceuticals
.

Which major investors are selling Eloxx Pharmaceuticals stock?

ELOX stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc..
View insider buying and selling activity for Eloxx Pharmaceuticals
.

Which major investors are buying Eloxx Pharmaceuticals stock?

ELOX stock was bought by a variety of institutional investors in the last quarter, including State Street Corp.
View insider buying and selling activity for Eloxx Pharmaceuticals
.

How do I buy shares of Eloxx Pharmaceuticals?

Shares of ELOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Eloxx Pharmaceuticals' stock price today?

One share of ELOX stock can currently be purchased for approximately $2.96.

How big of a company is Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals has a market capitalization of $118.85 million. Eloxx Pharmaceuticals employs 29 workers across the globe.

What is Eloxx Pharmaceuticals' official website?

The official website for Eloxx Pharmaceuticals is www.eloxxpharma.com.

How can I contact Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals' mailing address is 950 WINTER STREET, WALTHAM MA, 02451. The company can be reached via phone at 858-909-0749 or via email at [email protected]

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.